TREATMENT OF FIBROSIS USING FXR LIGANDS

World Intellectual Property Organization Patent

APP PUB NO WO-2005089316-A2
SERIAL NO

PCTUS2005008575

Stats

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a method for inhibiting fibrosis that occurs in an organ where the farnesoid X receptor (FXR) is expressed. This method involves the step of administering a high potency, activating ligand of FXR in an effective amount to a patient who is not suffering from a cholestatic condition. The invention also provides pharmaceutical compositions containing an effective amount of an FXR ligand and kits for dispensing the pharmaceutical compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • Owner owned or assignment not recorded

International Classification(s)

  • No Non-US Classification to display

Inventor(s)

  • No Inventor to display

Cited Art Landscape

Load Citation